Astragaloside IV drug-loaded exosomes (AS-IV EXOs) derived from endothelial progenitor cells improve the viability and tube formation in high-glucose impaired human endothelial cells by promoting miR-214 expression | Zendy

Xiaoling Zou | Zendy; Hui Xiao | Zendy; Xue Bai | Zendy; Yixian Zou | Zendy; Wenxiao Hu | Zendy; Xiangdong Lin | Zendy; Chenhong Zhu | Zendy; Yao Liang | Zendy; Wu Xiong | Zendy

Open Access

Astragaloside IV drug-loaded exosomes (AS-IV EXOs) derived from endothelial progenitor cells improve the viability and tube formation in high-glucose impaired human endothelial cells by promoting miR-214 expression

Author(s) -

Xiaoling Zou,

Hui Xiao,

Xue Bai,

Yixian Zou,

Wenxiao Hu,

Xiangdong Lin,

Chenhong Zhu,

Yao Liang,

Wu Xiong

Publication year - 2022

Publication title -

endokrynologia polska

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.413

H-Index - 27

eISSN - 2299-8306

pISSN - 0423-104X

DOI - 10.5603/ep.a2022.0011

Subject(s) - dapi , microvesicles , umbilical vein , progenitor cell , angiogenesis , endothelial progenitor cell , endothelial stem cell , transfection , viability assay , western blot , vasculogenesis , chemistry , cell , microbiology and biotechnology , cancer research , cell culture , biology , stem cell , apoptosis , microrna , in vitro , biochemistry , gene , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research